Coronavirus: We only approved Chloroquine as clinical trial - NAFDAC

  • 📰 PremiumTimesng
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 78%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

The National Agency for Food and Drug Administration and Control (NAFDAC) has only given its approval to May and Baker, a Pharmaceutical Company, to produce more Chloroquine as a clinical trial for the cure of coronavirus.

The NAFDAC’s Director-General, Mojisola Adeyeye, said this in a statement made available to the News Agency of Nigeria in Abuja on Saturday.

She said the trial was also necessary since coronavirus symptoms were similar to that of malaria; hence, the need to give Chloroquine a trial in the regard.“Directive has been given to May and Baker to manufacture the drug in case it will be needed on emergency in the country.’’ The NAFDAC boss said that part of the agency’s responsibilities was to ensure that Nigerians have access to safe and essential medicines.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Which means is not a sure drug for it ,like me chloroquine don't work in my system.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines